Allergan to buy dry eye disease-treatment maker Oculeve for $125 million
July 06, 2015 at 07:47 AM EDT
Botox maker Allergan PLC agrees to buy dry-eye disease treatment maker Oculeve for $125 million in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.